Standard Biotools Stock Technical Analysis

LAB Stock  USD 1.13  0.04  3.42%   
As of the 1st of March, Standard Biotools has the Variance of 18.48, coefficient of variation of (2,003), and Risk Adjusted Performance of (0.03). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Standard Biotools, as well as the relationship between them.

Standard Biotools Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Standard, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to StandardStandard Biotools' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Standard Biotools Analyst Consensus

Target PriceConsensus# of Analysts
1.55Strong Buy3Odds
Standard Biotools current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Standard analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Standard stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Standard Biotools, talking to its executives and customers, or listening to Standard conference calls.
Standard Analyst Advice Details
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Standard Biotools. Expected growth trajectory for Standard significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Standard Biotools assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.39)
Revenue Per Share
0.224
Quarterly Revenue Growth
(0.14)
Return On Assets
(0.1)
Return On Equity
(0.13)
The market value of Standard Biotools is measured differently than its book value, which is the value of Standard that is recorded on the company's balance sheet. Investors also form their own opinion of Standard Biotools' value that differs from its market value or its book value, called intrinsic value, which is Standard Biotools' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Standard Biotools' market value can be influenced by many factors that don't directly affect Standard Biotools' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Standard Biotools' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Standard Biotools represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Standard Biotools' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.

Standard Biotools 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Standard Biotools' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Standard Biotools.
0.00
12/01/2025
No Change 0.00  0.0 
In 2 months and 31 days
03/01/2026
0.00
If you would invest  0.00  in Standard Biotools on December 1, 2025 and sell it all today you would earn a total of 0.00 from holding Standard Biotools or generate 0.0% return on investment in Standard Biotools over 90 days. Standard Biotools is related to or competes with SANUWAVE Health,, 908 Devices, Sight Sciences, Outset Medical, Nano X, Senseonics Holdings, and CVRx. Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researche... More

Standard Biotools Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Standard Biotools' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Standard Biotools upside and downside potential and time the market with a certain degree of confidence.

Standard Biotools Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Standard Biotools' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Standard Biotools' standard deviation. In reality, there are many statistical measures that can use Standard Biotools historical prices to predict the future Standard Biotools' volatility.
Hype
Prediction
LowEstimatedHigh
0.061.125.44
Details
Intrinsic
Valuation
LowRealHigh
0.071.345.66
Details
Naive
Forecast
LowNextHigh
0.031.345.66
Details
3 Analysts
Consensus
LowTargetHigh
1.411.551.72
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Standard Biotools. Your research has to be compared to or analyzed against Standard Biotools' peers to derive any actionable benefits. When done correctly, Standard Biotools' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Standard Biotools.

Standard Biotools March 1, 2026 Technical Indicators

Standard Biotools Backtested Returns

Standard Biotools owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0647, which indicates the firm had a -0.0647 % return per unit of risk over the last 3 months. Standard Biotools exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Standard Biotools' Variance of 18.48, risk adjusted performance of (0.03), and Coefficient Of Variation of (2,003) to confirm the risk estimate we provide. The entity has a beta of 1.71, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Standard Biotools will likely underperform. At this point, Standard Biotools has a negative expected return of -0.28%. Please make sure to validate Standard Biotools' treynor ratio, skewness, and the relationship between the jensen alpha and value at risk , to decide if Standard Biotools performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.15  

Insignificant predictability

Standard Biotools has insignificant predictability. Overlapping area represents the amount of predictability between Standard Biotools time series from 1st of December 2025 to 15th of January 2026 and 15th of January 2026 to 1st of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Standard Biotools price movement. The serial correlation of 0.15 indicates that less than 15.0% of current Standard Biotools price fluctuation can be explain by its past prices.
Correlation Coefficient0.15
Spearman Rank Test-0.29
Residual Average0.0
Price Variance0.03
Standard Biotools technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Standard Biotools technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Standard Biotools trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Standard Biotools Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Standard Biotools across different markets.

About Standard Biotools Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Standard Biotools on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Standard Biotools based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Standard Biotools price pattern first instead of the macroeconomic environment surrounding Standard Biotools. By analyzing Standard Biotools's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Standard Biotools's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Standard Biotools specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2023 2024 2025 2026 (projected)
Payables Turnover6.057.347.915.26
Days Of Inventory On Hand134.09164.9170.45195.83

Standard Biotools March 1, 2026 Technical Indicators

Most technical analysis of Standard help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Standard from various momentum indicators to cycle indicators. When you analyze Standard charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Standard Biotools March 1, 2026 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Standard stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

Complementary Tools for Standard Stock analysis

When running Standard Biotools' price analysis, check to measure Standard Biotools' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Standard Biotools is operating at the current time. Most of Standard Biotools' value examination focuses on studying past and present price action to predict the probability of Standard Biotools' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Standard Biotools' price. Additionally, you may evaluate how the addition of Standard Biotools to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes